Author(s):
Rifa’atul Mahmudah, I Ketut Adnyana, Elin Yulinah Sukandar
Email(s):
ifamahmudah11@gmail.com
DOI:
10.5958/0974-360X.2020.00955.5 
Address:
Rifa’atul Mahmudah1,2*, I Ketut Adnyana1, Elin Yulinah Sukandar1
1Pharmacology and Clinical Pharmacy Department, School of Pharmacy, Bandung Institute of Technology, West Java, Indonesia.
2Pharmacy, STIKES Mandala Waluya Kendari, Southeast Sulawesi, Indonesia.
*Corresponding Author
Published In:
Volume - 13,
Issue - 11,
Year - 2020
ABSTRACT:
Garcinia mangostana Linn. or mangosteen through various parts of the plant and its contents are widely used as an alternative medicine for various diseases by assessing their pharmacological effects, including antidiabetec, antihyperlipidemia, antiobesity, antioxidants, analgesic, anti-inflammatory, anticancer, antidepressant, antibacterial, renoprotective, and neuroprotective. This material is easy to find and even found in Indonesia, Malay, Myanmar, Thailand, Cambodia, and Vietnam, and even has been cultivated in tropical regions such as India, Honduras, Brazil, and Australia. Research on Mangosteen continues to grow, both in vivo, in vitro, and in silico from year to year until now, this can be seen from various publications conducted by researchers. This can be a reference to make mangosteen as alternative medicine that can be widely used by the community, especially in terms of pharmacological effects.
Cite this article:
Rifa’atul Mahmudah, I Ketut Adnyana, Elin Yulinah Sukandar. Pharmacological effects of Garcinia mangostana L.: An Update Review. Research J. Pharm. and Tech. 2020; 13(11):5471-5476. doi: 10.5958/0974-360X.2020.00955.5
Cite(Electronic):
Rifa’atul Mahmudah, I Ketut Adnyana, Elin Yulinah Sukandar. Pharmacological effects of Garcinia mangostana L.: An Update Review. Research J. Pharm. and Tech. 2020; 13(11):5471-5476. doi: 10.5958/0974-360X.2020.00955.5 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-11-70
REFERENCES:
1. Nabavi SM, Silva AS. Nonvitamin and Nonmineral Nutritional Supplements. Academic Press, India. 2019; 545-552.
2. Iswari. High Efficacy Mangosteen Rind. Jakarta: Madya Centradifa. 2011.
3. Manimekalai I, Sivakumari K, Ashok K, Rajesh S. Phytochemical Profiling of Mangosteen Fruit, Garcinia mangostana. World J Pharm Pharm Sci. 2016; 5(2): 221-52.
4. Ovalle-Magallanes B, Eugenio-Pérez D, Pedraza-Chaverri J. Medicinal Properties of Mangosteen (Garcinia mangostana L.): a Comprehensive Update. Food and Chemical Toxicology. 2017; 109: 102-122.
5. Gutierrez-Orozco F, Failla ML. Biological Activities And Bioavailability Of Mangosteen Xanthones: A Critical Review Of The Current Evidence. Nutrients. 2013; 5(8): 3163-83.
6. Yang R, Li P, Li N, Zhang Q, Bai X, Wang L, Xiao Y, Sun L, Yang Q, Yan J. Xanthones from the pericarp of Garcinia mangostana. Molecules. 2017; 22(5): 683.
7. Ibrahim SRM, Mohamed GA, Khayat MT, Ahmed S, Abo-Haded H, Alshali KZ. Mangostanaxanthone VIIII, a new xanthone from Garcinia mangostana pericarps, α-amylase inhibitory activity, and molecular docking studies. Revista Brasileira de Farmacognosia. 2019; 29: 206-212.
8. Mirawati. Interaksi Farmakokinetik dan Farmakodinamik Ekstrak Kulit Buah Manggis (Garcinia mangostana L.) dengan Glikazid dan Metformin pada Tikus Model Diabetik, Disertasi Program Doktor, Bandung, ITB. 2018.
9. Taher M, Zakaria TM, Susanti D, Zakaria ZA. Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. In normoglycaemic and streptozotocin-induced diabetic rats. MC Complementary and Alternative Medicine. 2016; 16: 2-12.
10. Karim N, Jeenduang N, Tangpong J. Renoprotective Effects of Xanthones Derivatives from Garcinia mangostana Against High Fat Diet and Streptozotocin-Induced Type II Diabetes in Mice. Walailak Journal. 2016; 15(2): 107 -116.
11. Naymul K, Nutjaree J, Jitbanjong T. Anti-Glycemic and Anti-Hepatotoxic Effects of Mangosteen Vinegar Rind from Garcinia mangostana Against HFD/STZ-Induced Type II Diabetes in Mice. Polish Journal of Food and Nutrition Sciences. 2018; 68(2): 163-169.
12. Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W, Xiang H. New Medicinal Properties of Mangostins: Analgesic Activity and Pharmacological Characterization of Active Ingredients from The Fruit Hull of Garcinia mangostana L. Pharmacol Biochem Behav. 2010; 95(2):166-72.
13. Widowati W, Laksmitawati D, Afifah E, Amalia A, Arinta Y, Rizal R, Suciati T. Mangosteen Peel Extract (Garcinia mangostana L.) as Protective Agent in Glucose-Induced Mesangial Cell as In Vitro Model of Diabetic Glomerulosclerosis. Iranian Journal of Basic Medical Sciences. 2018; 21(9): 972-977.
14. Ratwita W, Sukandar EY, Adnyana IK. Alpha Mangostin and Xanthone from Mangosteen (Garcinia mangostana L.) Role on Glucose Tolerance and Glucose Transporter-4 in Diabetes Mellitus. International Journal of Pharmacognosy and Phytochemical Research. 2017; 9(9): 1206-1212.
15. Kumari MS, Babu MK, Sulthana MR, Srinivas M, Prasanthi C. Diabetes Mellitus: Present status and Drug therapy Updates. Research Journal of Pharmacy and Technology. 2014; 7(1): 84-94.
16. Kamtekar S, Keer V. Management of Diabetes: A Review. Research Journal of Pharmacy and Technology. 2014; 7(9): 1065-1072.
17. Kim HM, Kim YM, Huh JH, Lee ES, Kwon MH, Lee BR, Ko HJ, Chung CH. α-Mangostin Ameliorates Hepatic Steatosis and Insulin Resistance by CC Chemokine Receptor Inhibition 2. PLoS ONE. 2017; 12(6): 1-16.
18. Kumar V, Bhatt PC, Kaithwas G, Rashid M, Al-Abbasi FA, Khan JAA, Anwar F, Verma A. α-Mangostin Mediated Pharmacological Modulation of Hepatic Carbohydrate Metabolism in Diabetes Induced Wistar Rat. Beni-Suef University Journal of Basic and Applied Sciences. 2016; 5: 255–276.
19. Godavari A, Amutha K. In vitro Antidiabetic Activity of Garcinia mangostana by Enzymatic Inhibition Assay. Research Journal of Pharmacy and Technology. 2017; 10(2): 508-512.
20. Abdallah HM, El-Bassossy HM, Mohamed GA, El-Halawany AM, Alshali KZ, Banjar ZM. Mangostanaxanthones III and IV: Advanced Glycation End-Product Inhibitors from The Pericarp of Garcinia mangostana. Journal of Natural Medicines. 2017; 71(1): 216–226.
21. Adnyana I.K. Abuzaid, U.S., Iskandar E.Y., Kurniati, N.F. Pancreatic Lipase and α-Amylase Inhibitory Potential of Mangosteen (Garcinia mangostana Linn.) Pericarp Extract, Ijmrhs, 2016; 5(1): 23-28.
22. Varghese GK, Abraham R, Chandran NN, Habtemariam S. Identification of Lead Molecules in Garcinia mangostana L. Against Pancreatic Cholesterol Esterase Activity: an In Silico Approach. Interdisciplinary Sciences: Computational Life Sciences. 2017; 1-10.
23. Adiputro DL, Khotimah H, Widodo MA, Romdoni R, Sargowo D. Effects of Ethanolic Extracts of Garcinia mangostana Fruit Pericarp on Oxidant-Antioxidant Status and Foam Cells in Atherosclerotic Rats, Oxid Antioxid Med Sci, 2 (1): 61-64.
24. Kusmayadi A, Bachtiar KR, Prayitno CH. The Effects of Mangosteen Peel (Garcinia mangostana L.) and Turmeric (Curcuma domestica Val) Flour Dietary Supplementation on The Growth Performance, Lipid Profile, and Abdominal Fat Content in Cihateup Ducks. Veterinary World. 2019; 12(9): 402-408.
25. Sahu J, Patel PK, Dubey B. Effects of Methanolic Extracts of Quisqualis indica (Aerial Parts) on Passive Smoking Induced Hyperlipidemia in Rats. Asian Journal of Pharmacy and Technology. 2013; 3(1): 26-29.
26. Warditiani NK, Astuti KW, Sari PMNA, Wirasuta IMAG. Antidyslipidemic Activity of Methanol, Ethanol and Ethyl Acetate Mangosteen rind (Garcinia mangostana L). Research Journal of Pharmacy and Technology. 2020; 13(1): 261-264.
27. Frank JC. A Comparative Study to assess the Prevalence of Obesity among Secondary School Students of selected Urban and Rural areas in Jammu. International Journal of Advances in Nursing Management. 2019; 2(7): 114-116.
28. Liu QY, Wang YT, Lin LG. New insights into the anti-obesity activity of xanthones from Garcinia mangostana. Food Function. 2015; 6(2): 383-393.
29. Abuzaid AS, Sukandar EY, Kurniati NF, Adnyana IK. Prevention of Obesity and Development of Metabolic Syndrome by Mangosteen (Garcinia Mangostana L) Pericarp Ethanolic Extract in Male Wistar Rats Fed with High-Fat Diet. International Journal of Pharmacy and Pharmaceutical Sciences. 2016; 8(5): 372-378.
30. Darsono L, Hidayat M, Maesaroh M, Fauziah N, Widowati W. Ex Vivo Study of Garcinia Mangostana L. (Mangosteen) Peel Extract and Xanthones as Anti-Adipogenesis in HEPG2 Cell Model. Int J Med Res Health Sci. 2015; 4(3): 566-571.
31. Widowati W, Laksmitawati D, Suherman J, Afifah E, Rizal R, Arinta Y, Rismawati, Qodariah L, Mozef T, Suciati T. Mangosteen Peel Extract (Garcinia mangostana L.) and its Constituents to Lower Lipid Content on Adipogenesis Cells Model (3T3-L1), Journal of Natural Remedies. 2018; 18(2), 41-48.
32. Arsana IN, Adiputra N, Pangkahila JA, Putra-Manuaba IB. Garcinia mangostana L. Rind Extract and Physical Training Reducing Oxidative Stress in Wistar Rats During Maximal Physical Activity. Indonesia Journal of Biomedical Science. 2014; 7(2): 63-68.
33. Tjahjani S, Widowati W, Khiong K, Suhendra A, Tjokropranoto R. Antioxidant Properties of Garcinia mangostana L. (Mangosteen) Rind. Procedia Chemistry 2014; 13: 198 – 203.
34. Gunasekaran B, Muralidharan P, Pandiselvi A, Amutha P. Preliminary Phytochemical Screening and Antioxidant Activities of Ethanolic Extract of Caesalpinia sappan Linn. Research Journal of Pharmacy and Technology. 2008; 3(1): 179-181.
35. Kumar M, Sonia K, Madhan R, Selvakumar K, Kalaichelvan PT. Antiyeast, Antioxidant and Anticancer Activity of Tribulus terrestris Linn and Bougainvillea spectabilis Linn. Research Journal of Pharmacy and Technology. 2011; 4(9): 1483-1489.
36. Suthammarak W, Numpraphrut P, Charoensakdi R, Neugton N, Tunrungruangtavee V, Jaisupa N, Charoensak S, Moongkarndi P, Muangpaisan W. Antioxidant-Enhancing Property of the Polar Fraction of Mangosteen Pericarp Extract and Evaluation of Its Safety in Humans. Oxidative Medicine and Cellular Longevity. 2016; 1: 1-10.
37. Fu T, Wang S, Liu J, Cai E, Li H, Li P, Zhao Y. Protective Effects Of α-Mangostin Against Acetaminophen-Induced Acute Liver Injury in Mice. European Journal of Pharmacology. 2018; 173-180.
38. Aseena R, Zaidi SZH, Rasheed N, Mohammad AS. Anti-Asthmatic, Analgesic and Anti-Convulsant Activities of The Medicinal Plant Bryonia laciniosa Linn. Contributors. Asian Journal of Pharmaceutical Research. 2017; 4(7): 256-260.
39. Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W, Xiang H. New Medicinal Properties of Mangostins: Analgesic Activity and Pharmacological Characterization of Active Ingredients from The Fruit Hull of Garcinia mangostana L. Pharmacol Biochem Behav. 2010; 95(2):166-72.
40. Romain C, Cases J. Mangosteen Extract for Short-Term Pain Management Preclinical Approach and Pilot Clinical Investigation on Volunteers with Soft Tissue Pain. Agro FOOD Industry Hi Tech. 2015; 26(3): 8-13.
41. Putri K, Darsono L, Mandalas H. Anti-inflammatory Properties of Mangosteen Peel Extract on The Mice Gingival Inflammation Healing Process. Padjadjaran Journal of Dentistry. 2017;29(3):190-195.
42. Muchtaridi M, Afiranti FS, Puspasari PW, Subarnas A, Susilawati Y. Cytotoxicity of Garcinia mangostana L. Pericarp Extract, Fraction, and Isolate on Hela Cervical Cancer Cells. Journal of Pharmaceutical Sciences and Research. 2018;10(2): 348-351.
43. Laksmiani NPL, Reynaldi KR, Widiastari MI, Nugraha IPW, Suyadnya IMK, Maharan RAIK. Cytotoxic Activity of Andrographolide in Colon Cancer Through Inhibition Cox-2 by In Silico Study. International Conference on Mathematics and Natural Sciences. 2018; 1040: 1-6.
44. Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X. α-Mangostin Suppresses the Viability and Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells by Downregulating the PI3K/Akt Pathway. BioMed Research International. 2014; 1-12.
45. Kwak HH, Kim IR, Kim HJ, Park BS, Yu SB. α-Mangostin Induces Apoptosis and Cell Cycle Arrest in Oral Squamous Cell Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine. 2016; 1- 10.
46. Uppala PK, Krishna M, Kumar KA, Ramji V. Experimental Evaluation of Antidepressant activity of Aqueous and Methanolic Leaf and Shoot Extracts of Ageratum conyzoides Linn in Mice. Asian Journal of Pharmaceutical Research. 2016; 3(6): 153-158.
47. Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Chee HN, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo J, Walder K, Sarris J, Berk M. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Frontiers Psychiatry. 2019; 10(115): 1-17.
48. Ashton MM, Berk M, Chee HN, Hopwood M, Dodd S, Turner A, Brown BE, Jacka FN, Cotton SM, Khoo J, Chatterton ML, Kavanagh BE, Nadjidai SE, Monaco SLL, Harvey BH, Sarris J, Malhi GS, Dowling NL, Dean OM. Efficacy of Adjunctive Garcinia mangostana Linn (Mangosteen) Pericarp for Bipolar Depression: Study Protocol for a Proof-Of-Concept Trial. Brazilian Journal of Psychiatry. 2018; 1-9.
49. Oberholzer I, Möller M, Holland B, Dean OM, Berk M, Harvey BH. Garcinia mangostana Linn Displays Antidepressant-like and Pro-cognitive Effects in a Genetic Animal Model of Depression: a Bio-Behavioral Study in the Flinders Sensitive Line Rat. Metabolic Brain Disease. 2018; 33(2): 467-480.
50. Sivaranjani M, Leskinen K, Aravindraja C, Saavalainen P, Pandian SK, Skurnik M, Skurnik M, Ravi AV. Deciphering the Antibacterial Mode of Action of Alpha-Mangostin on Staphylococcus epidermidis RP62A Through an Integrated Transcriptomic and Proteomic Approach. Frontiers in Microbiology. 2019; 10: 1-16.
51. Anggia V, Bakhtiar A, Arbain D. The Isolation of Xanthones from Trunk Latex of Garcinia mangostana Linn. and Their Antimicrobial Activities. Indonesian Journal of Chemistry. 2015; 15(2): 187-193.
52. Al-Massarani BC, El Gamal AA, Al-Musayeib NM, Mothana RA, Basudan OA, Al-Rehaily AJ, Farag M, Assaf MH, El Tahir KH, Maes L. Phytochemical, Antimicrobial and Antiprotozoal Evaluation of Garcinia Mangostana Pericarp and α-Mangostin, Its Major Xanthone Derivatives. Molecules. 2013; 18: 10059-10608.
53. Ansori ANM, Susilo RJK, Hayaza S, Winarni D, Husen SA, Renoprotection by Garcinia mangostana L. Pericarp Extract in Streptozotocin-Induced Diabetic Mice. Iraqi Journal of Veterinary Sciences. 2019; 33(1): 13-19.
54. Janhom P, Dharmasaroja P. Neuroprotective Effects of Alpha-Mangostin on MPP+-Induced Apoptotic Cell Death in Neuroblastoma SH-SY5Y Cells. Journal of Toxicology. 2015; 1-11.
55. Hao XM, Li LD, Duan CL, Li YJ. Neuroprotective Effect of α-mangostin on Mitochondrial Dysfunction and α-synuclein Aggregation in Rotenone-Induced Models of Parkinson's Disease in Differentiated SH-SY5Y Cells. Journal of Asian Natural Products Research. 2017; 19(8): 833-845.
56. Jaisin Y, Ratanachamnong P, Kuanpradit C. Protective Effects of mang-mangostin on 6-OHDA-Induced Toxicity in SH-SY5Y Cells. Neuroscience Letters. 2018; 229-235.
57. Lee Y, Kim S, Oh Y, Kim YM, Chin YW, Cho J. Inhibition of Oxidative Neurotoxicity and ScopolamineInduced Memory Impairment by γ-Mangostin: in Vitro and in Vivo Evidence. Oxidative Medicine and Cellular Longevity. 2019; 1-14.